Astrana Health Inc. (ASTH)

Astrana Health's stock price has experienced a significant decline over the past six months. Key events impacting the stock include the Q3 2025 earnings report, which beat revenue expectations but missed GAAP profit estimates, leading to lowered full-year guidance due to delayed transition of payer contracts. The closing of the Prospect Health acquisition contributed to revenue growth but impacted profitability. The company reported strong Q2 2025 results, with total revenue up 35% and adjusted EBITDA at the higher end of guidance, and reiterated its full-year 2025 guidance at that time, inclusive of the Prospect Health acquisition.

While specific details are limited, Astrana Health likely experiences relatively stable demand throughout the year due to serving patients covered by various insurance plans, although certain medical conditions or elective procedures might exhibit minor seasonal fluctuations.

Astrana Health, Inc. is a healthcare management company that operates an integrated healthcare delivery platform in the United States, focusing on enabling providers to participate in value-based care arrangements to deliver high-quality and cost-effective care. Its platform offers a full spectrum of care, including Primary Care, Multi-Specialty Care, Immediate Care, Radiology, and Laboratory services. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement, with Care Partners generating the majority of revenue. Astrana Health provides care coordination services to patients covered by various insurance plans and leverages technology solutions to enhance healthcare delivery.

Headquartered in Alhambra, California, Astrana Health has expanded its geographic presence across Southern California, Texas, Arizona, and Rhode Island through strategic acquisitions, including Prospect Health Plan, Inc.

Astrana Health aims to maintain a positive brand reputation through patient-centered care and high-quality, cost-effective medical services, demonstrated by strong revenue growth. However, the name change from Apollo Medical Holdings, Inc., profitability challenges, and stock price decline may have impacted its reputation.

Astrana Health's ownership is primarily institutional and insider, with institutional shareholders holding 47.51% of the stock. Major institutional owners include BlackRock, Inc., Vanguard Group Inc., and State Street Corp. Key individual owners include Kenneth T. Sim, Thomas S. Lam, Albert Waichow Young, and Brandon Sim.